Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 121Sarcoma 47Lymphoid 37Genitourinary 30Myeloid 20Gastrointestinal 20Other hematologic neoplasm 15Gynecologic 12Dermatologic 11Plasma cell 10Endocrine 8Breast 7NET 6Other solid neoplasm 4Thoracic 2Head & Neck 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 76Anemia, Refractory, with Excess of Blasts 72Myelodysplastic Syndromes 69Leukemia 54Precursor Cell Lymphoblastic Leukemia-Lymphoma 51Anemia 50Leukemia, Lymphocytic, Chronic, B-Cell 44Leukemia, Myelomonocytic, Chronic 42Lymphoma, Non-Hodgkin 41Multiple Myeloma 39Hodgkin Disease 36Myeloproliferative Disorders 34Primary Myelofibrosis 33Thrombocytopenia 32Leukemia, Myelogenous, Chronic, BCR-ABL Positive 32Lymphoma 31Neoplasms 29Anemia, Aplastic 29Congenital Abnormalities 27Anemia, Refractory 25Lymphoma, Follicular 23Lymphoma, Mantle-Cell 21Lymphoma, B-Cell, Marginal Zone 18Burkitt Lymphoma 18Lymphoma, Large B-Cell, Diffuse 17Leukemia, Myeloid, Chronic-Phase 17Venous Thromboembolism 16Lymphoma, Large-Cell, Immunoblastic 16Leukemia, Myeloid, Accelerated Phase 16Waldenstrom Macroglobulinemia 14

Interventions

thymoglobulin 1fosphenytoin 1fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Thiotepa 1Phenytoin 1Melphalan 1Cyclophosphamide 1Busulfan 1Antilymphocyte Serum 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Neuroblastoma × Classical hematology × Clear all
NCT00801931 2019-03-27

Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders

Columbia University

Phase 1/2 Terminated
1 enrolled 8 charts
CNSClassical hematologyLymphoidOther hematologic neoplasm

Anemia, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡